FDA Commissioner Marty Makary called these changes “common-sense reforms” that could expedite the development of cell and ...

Clinical and commercial quality controls are eased as the FDA looks to expedite therapy approvals in areas of unmet need.

Next-generation automation is closing the gap between curative science and real-world demand, enabling faster development, ...

Reliance Industries Ltd. has halted its plans to manufacture lithium-ion battery cells in India due to the inability to ...